Cargando…
Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples
In recent years, research on glioma immunotherapy have grown rapidly. However, the autoimmune‐like side effects that are caused by blocking immunological checkpoints hinder their clinical application in gliomas currently. Galectin‐9, a ligand for T‐cell immunoglobulin mucin 3, has shed a new light o...
Autores principales: | Yuan, Feng, Ming, Haolang, Wang, Yingshuai, Yang, Yihan, Yi, Li, Li, Tao, Ma, Haiwen, Tong, Luqing, Zhang, Liang, Liu, Peidong, Li, Jiabo, Lin, Yu, Yu, Shengping, Ren, Bingcheng, Yang, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028024/ https://www.ncbi.nlm.nih.gov/pubmed/31609000 http://dx.doi.org/10.1002/jcp.29309 |
Ejemplares similares
-
Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation
por: Tao, Zhennan, et al.
Publicado: (2018) -
Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses
por: Yuan, Feng, et al.
Publicado: (2019) -
NKCC1 promotes EMT‐like process in GBM via RhoA and Rac1 signaling pathways
por: Ma, Haiwen, et al.
Publicado: (2018) -
Three-dimensional hydrogel is suitable for targeted investigation of amoeboid migration of glioma cells
por: Huang, Yubao, et al.
Publicado: (2018) -
Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4
por: Yi, Li, et al.
Publicado: (2019)